Trastuzumab Recruiting Phase 1 Trials for Neoplasms, Breast / Healthy Volunteers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02057133A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
NCT02581748A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German) in Healthy Chinese Male Subjects